Clinical Trials Browser

Phase 1/2 × Liposarcoma × toripalimab × Clear all

NCT04785196 2025-02-26

APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

Phase 1/2 Recruiting

Liposarcoma